1. Search Result
Search Result
Results for "

2079939-05-0

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-132832
    Sirpiglenastat

    DRP-104

    Others Cancer
    Sirpiglenastat (DRP-104) is a broad acting glutamine antagonist. Sirpiglenastat has anticancer effects by directly targeting tumor metabolism and simultaneously inducing a potent antitumor immune response.